Development of a New Reverse Genetics System for Ebola Virus

Area of Science:

• Virology
• Molecular Biology
• Infectious Diseases

Background:

• Ebola virus (EBOV) is a highly pathogenic virus responsible for deadly outbreaks.
• Existing EBOV reverse genetics systems require multiple plasmid transfections, posing technical challenges and limitations in mimicking natural virus propagation.
• There is a need for simplified and more versatile tools for studying EBOV replication and developing countermeasures.

Purpose of the Study:

• To establish a novel, simplified Ebola virus reverse genetics system.
• To enable the continuous propagation of EBOV subviral particles and rescue of infectious virions.
• To provide a versatile platform for studying EBOV replication, antiviral efficacy, and virus variant interactions.

Main Methods:

• Development of an engineered cell line stably expressing essential EBOV proteins (NP, VP35, VP30, L).
• Transfection of a single viral RNA genome into the engineered cell line to initiate replication.
• Production and propagation of EBOV subviral particles and rescue of infectious virions.

Main Results:

• A single-plasmid EBOV reverse genetics system was successfully established, simplifying experimental procedures.
• The system allows for continuous propagation of EBOV subviral particles and efficient rescue of infectious virions, independent of genome polarity or virus variant.
• The critical role of VP35 levels in optimal EBOV replication was identified, and the system demonstrated authentic antiviral responses.

Conclusions:

• The novel EBOV reverse genetics system offers a simplified and more efficient tool for EBOV research under various biosafety levels.
• This platform facilitates the study of EBOV life cycle, antiviral drug screening, and the rescue of diverse EBOV isolates.
• The findings contribute to advancing our understanding of EBOV pathogenesis and the development of effective control strategies.